Clinical trial
Predictive Value of a SNP Signature and Liquid Biopsy in Natural Killer T-cell Lymphoma
NCT04423536 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predictive Value of a SNP Signature and Liquid Biopsy in Natural Killer T-cell Lymphoma
- Lead sponsor
- Sun Yat-sen University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 9, 2021
- Completion date
- March 31, 2025
- Enrollment
- 800 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
natural killer t-cell lymphoma